GALECTIN THERAPEUTICS

Galectin Therapeutics is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Using these unique carbohydrate-ba... sed candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy. Galectin Therapeutic stock is traded on the NASDAQ under the symbol GALT. The company is located in a suburb of Atlanta known as Norcross, Georgia USA

#SimilarOrganizations #People #Financial #Website #More

GALECTIN THERAPEUTICS

Social Links:

Twitter

Facebook

Industry:

Biopharma Biotechnology Health Care Pharmaceutical

Founded:

2000-12-01

Address:

Norcross, Georgia, United States

Country:

United States

Website Url:

http://www.galectintherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

(678) 620-3186

Email Addresses:

[email protected]

Total Funding:

98.54 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome

Similar Organizations

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

Current Advisors List

not_available_image

Marc Rubin Board of Directors @ Galectin Therapeutics
Board_member
2011-10-01

not_available_image

Kevin Freeman Board of Directors @ Galectin Therapeutics
Board_member
2011-05-01

not_available_image

Irwin Joseph Goldstein Scientific Advisory Board @ Galectin Therapeutics
Advisor

gilbert-f-amelio_image

Gilbert F. Amelio Board of Directors @ Galectin Therapeutics
Board_member
2009-02-01

arthur-bobby-greenberg_image

Arthur "Bobby" Greenberg Board of Directors @ Galectin Therapeutics
Board_member
2009-08-01

john-mauldin_image

John Mauldin Board of Directors @ Galectin Therapeutics
Board_member
2011-05-01

not_available_image

Steven Prelack Board of Directors @ Galectin Therapeutics
Board_member
2003-04-01

not_available_image

Richard E Uihlein Board Member @ Galectin Therapeutics
Board_member
2022-07-26

Current Employees Featured

jack-w-callicutt_image

Jack W. Callicutt
Jack W. Callicutt CFO @ Galectin Therapeutics
CFO
2013-07-01

james-czirr_image

James Czirr
James Czirr Director and Founder @ Galectin Therapeutics
Director and Founder

harold-h-shlevin_image

Harold H. Shlevin
Harold H. Shlevin Consultant, Director @ Galectin Therapeutics
Consultant, Director

not_available_image

Eliezer Zomer
Eliezer Zomer Executive Vice President, Manufacturing and Product Development @ Galectin Therapeutics
Executive Vice President, Manufacturing and Product Development

joel-lewis_image

Joel Lewis
Joel Lewis Chief Executive Officer and President @ Galectin Therapeutics
Chief Executive Officer and President
2020-01-01

pol-f-boudes_image

Pol F. Boudes
Pol F. Boudes Chief Medical Officer @ Galectin Therapeutics
Chief Medical Officer
2020-03-01

Founder

not_available_image

Anatole Klyosov

james-czirr_image

James Czirr

Stock Details

Company's stock symbol is NASDAQ:GALT

Investors List

richard-e-uihlein_image

Official Site Inspections

http://www.galectintherapeutics.com

Host Informations
Whois Informations

Loading ...